pioneer 6 oral semaglutide cardiovascular outcomes trial results Efficacy and safety of once-daily 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b PIONEER 6: Oral Semaglutide Passes

Then, in April, tirzepatide (sold as Mounjaro and Zepbound) reported promising late-stage trial results for managing sleep apnea , a breathing condition, while other studies hinted it might also improve chronic kidney disease

Often referred to as the molecule of youth or cellular fuel, NAD+ plays a foundational role in converting the food we eat into the energy our cells need to function, repair themselves, and maintain overall health

119 The miR-590-3p secreted by M2 macrophage exosomes is transferred from macrophages to intestinal epithelial cells, activating the YAP/-catenin pathway and thereby promoting the proliferation of intestinal epithelial cells and wound healing and alleviating intestinal mucosal injury

66% of the included patients who underwent sleeve gastrectomy were enlisted for cardiac transplantation, with 33% successfully transplanted